Clinical Trials Directory

Trials / Terminated

TerminatedNCT03937856

Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases

Smartphone App Mindfulness-Based Intervention for Patients With Rheumatic Diseases

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will assess the effect of a mindfulness meditation program administered via a smartphone application on health-related quality of life for patients with rheumatic disease.

Detailed description

After obtaining written consent, participants will be asked to download and use the Calm meditation smartphone application everyday for a 30-day period. Participant demographics and clinical information will be collected at baseline. Participants will additionally be asked to complete questionnaires concerning health-related quality of life (HRQoL) as well as mental health, stress, and self-efficacy at baseline and at the end of the 30 day study period. A brief check-in via telephone will be conducted on day 15. Participants using the calm app will be compared to participants receiving usual care who will be asked to complete identical sets of questionnaires. The participant may choose whether they join the Calm application vs usual care (questionnaires only) group on a voluntary basis; there is no pre-assignment. The Calm application is a publicly available program that is available to any patient independent of this study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCalm- Mindfulness Meditation smartphone applicationParticipants will be asked to register and download the Calm application on participants' phones or home computer. Daily use for a minimum of 5 minutes will be suggested and will be recorded at study end.

Timeline

Start date
2019-05-07
Primary completion
2021-04-22
Completion
2021-04-22
First posted
2019-05-06
Last updated
2021-04-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03937856. Inclusion in this directory is not an endorsement.